Skip to the page

Data / Form D filings / Visor Health Inc.

Visor Health Inc.: Form D filings

Visor Health Inc., a biotechnology company in Louisville, KY, filed 2 Form D notices with the SEC between 2025 and 2026. The latest, on April 22, 2026, reports an offering of $3 million with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3723 TAYLORSVILLE ROAD SUITE B, Louisville, KY, 40220
Phone
(502) 817-9120
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2087088

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 22, 2026New notice$3,000,000$0$3,000,0000Yet to occursec.gov
Sep 19, 2025New notice$3,000,000$1,751,000$1,249,0009Jan 7, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Kevin RappExecutive Officer, Director
Paul MontanariExecutive Officer
Gordon GrohExecutive Officer
Chris PageExecutive Officer

Every Form D from the week of Apr 20, 2026 · All recent filings in Kentucky · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Visor Health Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.